Artificial Neural Network

Our Research.

We discover personalized medical solutions for environmentally triggered diseases.

Our Research.

We discover personalized medical solutions for environmentally triggered diseases.

On This Page

Research Highlights

Translation: Where Medical Research Reaches People

How can we bring new scientific insights to patients more quickly? At Helmholtz Munich, we work hand in hand with leading…

Nurse and patient in hospital bed with medical monitors

How Foundation Models Are Shaping Biomedical Research

AI-powered foundation models like GPT have evolved from everyday tools for simple tasks to powerful systems capable of…

An AI powered system automating remote patient monitoring by analyzing real time health data and vital signs, futuristic AI-driven healthcare platform_AdobeStock_1366228679

Science Through an Artistic Lens

In a world where scientific innovation is increasingly interconnected, the RepliFate-Artist in Residence program seeks to…

Cellular Reprogramming Necklace by Anna Dumitriu photo credit Audrey Rose Mizzi large_QUER

Tracing the First Building Blocks of Life

What connects Helmholtz Munich with space research? The globally unique analytical methods developed by Prof. Philippe…

Bennu polycam mosaic obtained before spacecraft arrival

Ali Ertürk’s Journey in Transformative Biomedical Imaging

Imagine a world where the most intricate networks and processes within whole bodies are visible – down to the level of…

Ali Ertürk with transparent mouse

Ferroptosis: Controlling Life or Death of Cells

Cell death is indispensable to life, as it ensures the removal of damaged or unnecessary cells. Among the many ways a cell can…

Apoptosis process in a cell

Germany’s Largest Biorepository

The largest repository of human biosamples in Germany is located at the Helmholtz Munich campus. It features cutting-edge…

Nako Eröffnung 2018; weltweit größten Stickstofftanks für Gesundheitsproben

Research News

Newborn care

Transfer, Computational Health, ICB, IML,

Helmholtz Munich and Partners Develop AI-Powered Sensor Patch for Neonatal Care

Researchers at Helmholtz Munich, together with international partners, have developed an ultrathin sensor patch capable of non-invasively monitoring key health parameters in preterm infants. The silk-based patch measures temperature, pH, sodium, and…

Akademiepreis für Fabian Theis

AI, Awards & Grants, Computational Health, ICB,

Fabian Theis Receives Akademiepreis of the Berlin-Brandenburg Academy of Sciences and Humanities

Prof. Fabian Theis has been awarded the Akademiepreis of the Berlin-Brandenburg Academy of Sciences and Humanities. The Academy honors his pioneering work in computational biomedicine and the development of novel methods for biomedical data analysis.…

Helmholtz Munich and Vector Institute Strengthen International AI Research Collaboration

AI, Transfer, Computational Health,

Helmholtz Munich and Vector Institute Strengthen International AI Research Collaboration

Helmholtz Munich and the Vector Institute have signed a Memorandum of Understanding (MOU) to strengthen international collaboration in artificial intelligence (AI) and machine learning. The agreement establishes a formal framework for joint research,…

Marcus Conrad Elected to the Leopoldina

Awards & Grants, Molecular Targets and Therapeutics, MCD,

Marcus Conrad Elected to the Leopoldina

Prof. Marcus Conrad has been elected a member of the German National Academy of Sciences Leopoldina. With this prestigious scientific honor, the Academy recognizes his outstanding contributions to the study of regulated cell death and its…

Heat Action Day 2026: WHO Presents New Guidance for Health-Related Heat Action Plans

Climate & Health, Environmental Health, EPI,

Heat Action Day 2026: WHO Presents New Guidance for Health-Related Heat Action Plans

On 11 June 2026, the nationwide Heat Action Day will take place in Germany under the motto “Preparing together for extreme heat.” The day aims to raise awareness of the health risks posed by extreme heat and strengthen measures to protect the…

HAICON 2026: Workshops & Tutorials Day at Helmholtz Munich

Events, AI, Computational Health,

HAICON 2026: Workshops & Tutorials Day at Helmholtz Munich

From 8 to 11 June 2026, HAICON 2026 will bring together researchers, developers and practitioners from academia and industry in Munich to discuss the latest developments and applications of artificial intelligence. Organized by Helmholtz AI, the…

Hungarian Government Appoints Péter Horváth as State Secretary for Science Policy and Innovation

Computational Health, AIH,

Hungarian Government Appoints Péter Horváth as State Secretary for Science Policy and Innovation

The newly formed Hungarian government has appointed Dr. Péter Horváth as State Secretary for Science Policy and Innovation. The internationally recognized computer scientist and AI researcher combines scientific excellence with extensive experience…

Echter Hopfen (Humulus lupulus)

Environmental Health, PGSB,

Decoding the Hop Genome to Help Protect the Future of Beer in a Warming World

Researchers from Helmholtz Munich, Hopsteiner and Carlsberg Research Laboratory have unveiled the most detailed genetic map of hops ever created – a major step toward protecting one of beer’s key ingredients from the growing impacts of climate…

central cancer cell being attacked by surrounding immune cells (t-cells). Ideal for medical, scientific, oncology, and health-related content

Transfer, Molecular Targets and Therapeutics, VIRO,

Helmholtz Munich Technologies and Champalimaud Foundation TCR Assets Support Cellular Immunotherapy Research

Helmholtz Munich has licensed fusion receptor technologies to the Champalimaud Foundation, where they are being used together with newly acquired T cell receptor assets to support research into engineered T cell therapies.

Institut für Diabetesforschung Studienzentrum

New Research Findings, Diabetes, IDF,

Early Detection of Type 1 Diabetes in Children Is Broadly Feasible

For ten years, the Fr1da study, coordinated by Helmholtz Munich, has been investigating whether early stages of type 1 diabetes in children can be detected in routine pediatric care. The latest evaluation shows that the screening program is…

Whole-body 3D reconstructions, AI segmentations and supplementary videos are available via the interactive online atlas at https://discotechnologies.org/MouseMapper/. High-resolution figures and animations are available on request.

New Research Findings, Diabetes, IDC, Bioengineering, iBIO,

AI Atlas Reveals Hidden Whole-Body-Damage Caused by Obesity

Researchers at Helmholtz Munich, the Ludwig Maximilians University Munich (LMU) and collaborating institutions have developed an artificial intelligence (AI) framework that maps disease-related changes throughout the entire mouse body at cellular…

M1 Medicine Alliance - Funded Projects

Transfer, Diabetes, IDC, Stem Cells, ISF,

M1 Launches First Funding Period and Advances Translation in Munich

With the launch of its first funding period, the M1 – Munich Medicine Alliance is entering its active translation phase in Munich. As part of the “Innovations for Patients” program, the alliance is funding seven research projects with a total of…

Portrait Stephan Herzig, Querformat;

Awards & Grants, Diabetes, IDC,

Stephan Herzig Receives the 2026 Friedrich Arnold Gries Award from the DDG

Prof. Stephan Herzig has been awarded the 2026 Friedrich Arnold Gries Award by the German Diabetes Association (DDG). The award recognizes his outstanding scientific work on “Molecular characterization and therapeutic exploitation of…

Michele Solimena

Awards & Grants, Diabetes, IPI,

Michele Solimena Honored With the 2026 Paul Langerhans Medal of the DDG

Prof. Michele Solimena received the Paul Langerhans Medal, the highest award of the German Diabetes Society (DDG), on May 15, 2026. The prize recognizes his outstanding lifetime scientific achievements in the field of diabetes research. The…

Predicting cell fate trajectories

AI, New Research Findings, Computational Health, ICB,

AI Model Makes Developmental Paths of Biological Cells Traceable

Researchers at Helmholtz Munich, the Technical University of Munich (TUM), the Stowers Institute for Medical Research, and the University of Oxford, have developed an AI-based model that not only traces the developmental paths of individual cells,…

20190122_Translatum_AH_503608

Bioengineering, ISBM,

Reading Genetic Activity from Living Cells without Destroying Them

Until now, studying the genetic processes in cells required destroying them - making it impossible to observe these processes over extended periods of time. A team from Helmholtz Munich and the Technical University of Munich (TUM) has developed a new…

Screenshot pancreas für research area "type 1 diabetes pathology" (Teresa Rodgriguez-Calvo)

Awards & Grants, Diabetes, IDF,

New Funding Supports Research into Causes and Treatment of Type 1 Diabetes

Dr. Teresa Rodriguez-Calvo from Helmholtz Munich has been awarded two prestigious grants from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support two innovative projects at the…

Institut für Diabetesforschung Studienzentrum

Diabetes, IDF,

Fr1da Study Expands Early Diabetes Detection to 12 German Federal States

As part of the Fr1da study, “Early detection and early treatment of type 1 diabetes”, led by researchers at the Institute of Diabetes Research at Helmholtz Munich, families can have their children aged two to ten tested for an early stage of type 1…

“Your Start to an Active Everyday Life” on diabinfo.de – Start Moving Today

Diabetes,

New Video Series on diabinfo.de for More Exercise in Everyday Life

Regular exercise is a key component of a healthy lifestyle and is particularly important for preventing type 2 diabetes and other non-communicable diseases. Nevertheless, many people find it difficult to incorporate sufficient exercise into their…

glucagon like peptide 1 glp1 7 36 molecule the glucagon like peptide 1 receptor has a strong effect on the management of type 2 diabetes mellitus

New Research Findings, Diabetes, IDO,

One Molecule, Two Effects: A New Drug Concept to Treat Obesity and Type 2 Diabetes

A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signalling pathway as a “door opener” and delivers an…

Our Research Centers

Helmholtz Diabetes Center

Computational Health Center

Stem Cell Center

Environmental Health Center

Bioengineering Center

Molecular Targets and Therapeutics Center

Helmholtz Pioneer Campus

Core Facilities

Core Facilities

Core facilities support and enable our center’s research by providing centralized access to cutting-edge technologies, instruments and highly skilled staff, fostering innovation and connecting scientists across disciplines.

Find out more
Artificial Intelligence in Healthcare - New AI Applications in Medicine

Transfer

Our cutting-edge research forms the basis for medical innovations. Together with our partners, we are accelerating the transfer of our research to bring new ideas from the laboratories to application even faster.
n addition to implementing innovative diagnostics, medical technologies, sustainable prevention measures and personalized therapeutics, we are shaping a dialogical and interactive transfer of knowledge. In this way, we make a valuable contribution to a healthier society.

More information
Vascular and glomeruli details of the human kidney.

Our Researchers

Eleftheria Zeggini

"We discover breakthrough solutions for better health in a rapidly changing world."

to Eleftheria's page

Eleftheria Zeggini

Prof. Dr. Eleftheria Zeggini

Program Director ENABLE

Stephan Herzig

"It is my vision to successfully drive a mechanistic finding into clinical application in the area of obesity-related metabolic dysfunction as well as cancer cachexia."

to Stephan's page

Prof.Dr. Steühan Herzig Bannerformat

Prof. Dr. Stephan Herzig

Director of the Diabetes Center, Scientific Director

Martin Hrabě de Angelis

"Leading science means guiding discovery toward public good – with excellence, integrity, and impact."

to Martin's page

Porträt Martin Hrabe de Angelis Querformat Background: Office / Indoorplant

Prof. Dr. Dr. h.c. Martin Hrabě de Angelis

Member and Spokesperson of the Executive Board (acting), Director of the Institute of Experimental Genetics, Scientific Director

Fabian Theis

"With AI we can imagine a future where diagnosing and treating diseases is more affordable, widely available, and thus more democratic."

to Fabian's page
Fabian Theis eingefärbt

Prof. Dr. Fabian Theis

Director of the Computational Health Center

Vasilis Ntziachristos

"Our research at Helmholtz Munich is driven by our interest to provide solutions that address critical unmet medical need and positively impact healthcare and the well-being of society."

Porträt Vasilis Ntziachristos, tuerkis Version 2

Prof. Dr. Vasilis Ntziachristos

Director of the Bioengineering Center

Erika von Mutius

"I am a passionate pediatrician scientist. My research focusses on the roots of asthma and allergy development with the aim of ultimately preventing these diseases in children at risk."

Prof. Dr. Erika von Mutius_freigestellt

Prof. Dr. Erika von Mutius

Director of the Environmental Health Center

Magdalena Götz

"My vision is to explore the mechanisms of neurogenesis to use it for instructing neurogenesis for replacement of lost neurons."

Magdalena Götz Porträt / 2014

Prof. Dr. Magdalena Götz

Director of the Stem Cell Center

Michael Sattler

"We combine integrative structural biology to elucidate molecular mechanisms of biological pathways, highlighting the essential roles of dynamics and transient regulatory interations to enable innovative structure-based drug discovery."

to Michael´s page
Michael Sattler_freigestellt

Prof. Dr. Michael Sattler

Director of the Molecular Targets & Therapeutics Center

Networks: Sponsors & Partners

We collaborate with a dynamic network of regional and international partners. Together, we engage in impactful projects and cooperations that shape the future of medicine.
Read more 

Blue and white sphere network structure - abstract design connection design - 3D illustration